{'52WeekChange': 1.5989847,
 'SandP52WeekChange': None,
 'address1': '2701 Kent Avenue',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 5.01,
 'askSize': 1400,
 'averageDailyVolume10Day': 56237,
 'averageVolume': 22676,
 'averageVolume10days': 56237,
 'beta': 1.460504,
 'beta3Year': None,
 'bid': 4.99,
 'bidSize': 1100,
 'bookValue': 0.91,
 'category': None,
 'circulatingSupply': None,
 'city': 'West Lafayette',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 5.23,
 'dayLow': 4.9157,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 40.38,
 'enterpriseToRevenue': 1.611,
 'enterpriseValue': 87907048,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '765 497 1102',
 'fiftyDayAverage': 5.049714,
 'fiftyTwoWeekHigh': 6.5,
 'fiftyTwoWeekLow': 1.97,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 7105348,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 311,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.34699002,
 'heldPercentInstitutions': 0.09398,
 'industry': 'Diagnostics & Research',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1569801600,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/basinc.com',
 'longBusinessSummary': 'Bioanalytical Systems, Inc., doing business as '
                        'Inotiv, a pharmaceutical development company, '
                        'provides drug discovery and development services, and '
                        'analytical instruments for pharmaceutical, '
                        'biotechnology, academic, and government organizations '
                        'in the United States, rest of North America, the '
                        'Pacific Rim, Europe, and internationally. It operates '
                        'through two segments, Contract Research Services and '
                        'Research Products. The Contract Research Services '
                        'segment offers screening and pharmacological testing, '
                        'nonclinical safety testing, formulation development, '
                        'regulatory compliance, and quality control testing '
                        'services. This segment also provides in vivo sampling '
                        'services for the continuous monitoring of chemical '
                        'changes in life; non-clinical toxicology and '
                        'pathology services; analytical method development and '
                        'validation; drug metabolism, bioanalysis, and '
                        'pharmacokinetics testing to measure drug and '
                        'metabolite concentrations in complex biological '
                        'matrices; stability testing to ensure the integrity '
                        'of various solutions used in nonclinical and clinical '
                        'studies, and post-study analyses; and '
                        'climate-controlled archiving services for its '
                        "customers' data and samples. The Research Products "
                        'segment offers analytical products comprising liquid '
                        'chromatographic and electrochemical instruments with '
                        'associated accessories; in vivo sampling products '
                        'consisting of Culex family of automated in vivo '
                        "sampling and dosing instruments; and Vetronics' "
                        'products, such as instruments and related software to '
                        'monitor and diagnose cardiac function, and measure '
                        'other vital physiological parameters in cats and dogs '
                        'in veterinary clinics. Bioanalytical Systems, Inc. '
                        'was founded in 1974 and is headquartered in West '
                        'Lafayette, Indiana.',
 'longName': 'Bioanalytical Systems, Inc.',
 'market': 'us_market',
 'marketCap': 54430144,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_25587',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -2150000,
 'nextFiscalYearEnd': 1632960000,
 'open': 5.15,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '765 463 4527',
 'previousClose': 5.12,
 'priceHint': 2,
 'priceToBook': 5.5054946,
 'priceToSalesTrailing12Months': 0.9973092,
 'profitMargins': -0.039389998,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 5.23,
 'regularMarketDayLow': 4.9157,
 'regularMarketOpen': 5.15,
 'regularMarketPreviousClose': 5.12,
 'regularMarketPrice': 5.15,
 'regularMarketVolume': 17262,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 10864300,
 'sharesPercentSharesOut': 0.002,
 'sharesShort': 21312,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 13174,
 'shortName': 'Bioanalytical Systems, Inc.',
 'shortPercentOfFloat': 0.0025,
 'shortRatio': 1.29,
 'startDate': None,
 'state': 'IN',
 'strikePrice': None,
 'symbol': 'BASI',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.212,
 'twoHundredDayAverage': 4.680072,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '7f6f1a23-500c-3ab6-a899-ac11996e6f02',
 'volume': 17262,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.basinc.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '47906'}